This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malik, S., Slevin, M. Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary - a new therapeutic approach?. Br J Cancer 63, 410–411 (1991). https://doi.org/10.1038/bjc.1991.94
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.94
This article is cited by
-
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03
Clinical and Translational Oncology (2023)
-
Recent Advances in Granulosa Cell Tumor Ovary: A Review
Indian Journal of Surgical Oncology (2013)
-
Hormonal Treatment in Recurrent and Metastatic Gynaecological Cancers: A Review of the Current Literature
Current Oncology Reports (2013)
-
Clinical applications of hormonal therapy in ovarian cancer
Current Treatment Options in Oncology (2005)